Article citationsMore>>

Bang, J.-H., Byeun, J.-Y., Choi, S.-Y., et al. A Phase III Multi-Center, Open-Label, Randomized Study of the Efficacy of Nilotinib versus Imatinib in Adult Patients With Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to Imatinib. ClinicalTrials.gov: US National Institutes of Health NCT01400074 Latest Information Update 2017.

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top